Back to GetFilings.com



Table of Contents
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

 
FORM 10-Q
(Mark One)
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
  
 
For the quarterly period ended September 28, 2002
 
OR
 
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
  
 
For the transition period from                              to                             
 
Commission file number: 000-49835
 

 
PILLOWTEX CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
 
DELAWARE
 
75-2147728
(State of Incorporation)
 
(IRS Employer Identification No.)
     
One Lake Circle Drive, Kannapolis, North Carolina
 
28081
(Address of Principal Executive Offices)
 
(Zip Code)
 
(704) 939-2000
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x  No  ¨
 
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes  x  No  ¨
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
Class

    
Outstanding at November 1, 2002

Common Stock, $0.01 par value
    
19,095,215
 

 


Table of Contents
PILLOWTEX CORPORATION AND SUBSIDIARIES
 
INDEX
 
           
Page No.

Part I—Financial Information
      
Item 1.
  
Unaudited Consolidated Financial Statements:
      
         
2
         
3
         
4
         
5
         
6
         
8
Item 2.
       
28
Item 3.
       
38
Item 4.
       
38
Part II—Other Information
      
Item 6.
       
39
    
40
    
41


Table of Contents
PILLOWTEX CORPORATION AND SUBSIDIARIES
 
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except for par value)
 
    
Successor

    
Predecessor

 
    
September 28,
2002

    
September 29,
2001

    
December 29,
2001

 
ASSETS
                      
Current assets:
                      
Cash and cash equivalents (including restricted cash of $1,764 as of September 28, 2002 and $3,861 as of December 29, 2001)
  
$
6,547
 
  
23,414
 
  
40,388
 
Receivables:
                      
Trade, less allowances of $9,665 as of September 28, 2002, $14,770 as of September 29, 2001 and $9,276 as of December 29, 2001
  
 
161,561
 
  
183,332
 
  
144,727
 
Other
  
 
2,852
 
  
6,193
 
  
4,478
 
Inventories
  
 
212,452
 
  
205,198
 
  
200,578
 
Assets held for sale
  
 
18,508
 
  
6,889
 
  
6,075
 
Prepaid expenses
  
 
5,694
 
  
5,774
 
  
3,604
 
Net assets of discontinued operations
  
 
—  
 
  
9,406
 
  
1,358
 
    


  

  

Total current assets
  
 
407,614
 
  
440,206
 
  
401,208
 
Property, plant and equipment, less accumulated depreciation of $4,564 as of September 28, 2002, $170,273 as of September 29, 2001 and $172,938 as of December 29, 2001
  
 
169,456
 
  
474,469
 
  
453,440
 
Intangible assets, at cost less accumulated amortization of $484 as of September 28, 2002, $37,521 as of September 29, 2001 and $40,899 as of December 29, 2001
  
 
48,548
 
  
224,619
 
  
221,729
 
Other assets
  
 
3,677
 
  
33,678
 
  
11,250
 
    


  

  

Total assets
  
$
629,295
 
  
1,172,972
 
  
1,087,627
 
    


  

  

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
                      
Liabilities not subject to compromise:
                      
Current liabilities:
                      
Checks not yet presented for payment
  
$
9,829
 
  
9,250
 
  
285
 
Accounts payable
  
 
45,741
 
  
37,888
 
  
34,834
 
Accrued expenses
  
 
88,940
 
  
63,321
 
  
59,837
 
Current portion of long-term debt
  
 
6,253
 
  
322
 
  
356
 
Current portion of long-term debt in default
  
 
—  
 
  
667,447
 
  
660,893
 
Long-term debt in default
  
 
—  
 
  
12,429
 
  
10,920
 
    


  

  

Total current liabilities
  
 
150,763
 
  
790,657
 
  
767,125
 
Long-term debt, less current portion
  
 
230,253
 
  
658
 
  
645
 
Noncurrent liabilities
  
 
64,422
 
  
38,595
 
  
48,950
 
    


  

  

Total liabilities not subject to compromise
  
 
445,438
 
  
829,910
 
  
816,720
 
Liabilities subject to compromise
  
 
—  
 
  
496,465
 
  
500,840
 
    


  

  

Total liabilities
  
 
445,438
 
  
1,326,375
 
  
1,317,560
 
Predecessor Series A redeemable convertible preferred stock, $0.01 par value; 81,411 shares issued and outstanding for September 29, 2001 and December 29, 2001
  
 
—  
 
  
94,827
 
  
99,185
 
Stockholders’ equity (deficit):
                      
Successor preferred stock, $0.01 par value; authorized 10,000,000 shares
  
 
—  
 
  
—  
 
  
—  
 
Predecessor preferred stock, $0.01 par value; authorized 20,000,000 shares; only Series A issued
  
 
—  
 
  
—  
 
  
—  
 
Successor common stock, $0.01 par value; authorized 50,000,000 shares; 19,095,215 shares issued and outstanding
  
 
191
 
  
—  
 
  
—  
 
Predecessor common stock, $0.01 par value; authorized 55,000,000 shares; 14,250,892 shares issued and outstanding as of September 29, 2001 and December 29, 2001
  
 
—  
 
  
143
 
  
143
 
Additional paid-in capital
  
 
195,118
 
  
160,120
 
  
160,120
 
Accumulated deficit
  
 
(10,289
)
  
(406,659
)
  
(461,186
)
Deferred compensation
  
 
(1,188
)
  
—  
 
  
—  
 
Accumulated other comprehensive income (loss)
  
 
25
 
  
(1,834
)
  
(28,195
)
    


  

  

Total stockholders’ equity (deficit)
  
 
183,857
 
  
(248,230
)
  
(329,118
)
Commitments and contingencies
                      
    


  

  

Total liabilities and stockholders’ equity (deficit)
  
$
629,295
 
  
1,172,972
 
  
1,087,627
 
    


  

  

 
See accompanying notes to consolidated financial statements.

2


Table of Contents
 
PILLOWTEX CORPORATION AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended September 28, 2002 and September 29, 2001
(Dollars in thousands, except for per share data)
 
    
Successor

    
Predecessor

 
    
Three Months
Ended
September 28,
2002

    
Three Months
Ended
September 29,
2001

 
Net sales
  
$
242,528
 
  
266,316
 
Cost of goods sold
  
 
223,850
 
  
258,962
 
    


  

Gross profit
  
 
18,678
 
  
7,354
 
Selling, general, and administrative expenses
  
 
22,645
 
  
16,244
 
Impairment of long-lived assets
  
 
—  
 
  
3,085
 
Restructuring charges
  
 
365
 
  
26
 
    


  

Loss from operations
  
 
(4,332
)
  
(12,001
)
Interest expense (contractual interest of $23,509 in 2001)
  
 
4,948
 
  
14,942
 
    


  

Loss from continuing operations before reorganization items and income taxes
  
 
(9,280
)
  
(26,943
)
Reorganization items:
               
Gain on cancellation of pre-petition liabilities
  
 
—  
 
  
—  
 
Fresh start adjustments
  
 
—  
 
  
—  
 
Other
  
 
—  
 
  
4,590
 
    


  

Total reorganization items
  
 
—  
 
  
4,590
 
    


  

Loss from continuing operations before income taxes
  
 
(9,280
)
  
(31,533
)
Income tax benefit
  
 
—  
 
  
—  
 
    


  

Net loss from continuing operations
  
 
(9,280
)
  
(31,533
)
Discontinued operations:
               
Loss from operations
  
 
—  
 
  
(8,899
)
Loss on disposal
  
 
—  
 
  
(3,256
)
    


  

Loss from discontinued operations
  
 
—  
 
  
(12,155
)
    


  

Net loss
  
 
(9,280
)
  
(43,688
)
Preferred dividends and accretion
  
 
—  
 
  
4,604
 
    


  

Loss applicable to common stockholders
  
$
(9,280
)
  
(48,292
)
    


  

Basic and diluted loss per common share—  
               
Loss applicable to common stockholders
  
$
(0.49
)
      
    


      
Weighted average common shares outstanding—  
               
Basic and diluted
  
 
19,026
 
      
    


      
 
See accompanying notes to consolidated financial statements.

3


Table of Contents
 
PILLOWTEX CORPORATION AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF OPERATIONS
Four Months Ended September 28, 2002,
Five Months Ended June 1, 2002 and
Nine Months Ended September 29, 2001
(Dollars in thousands)
 
    
Successor

    
Predecessor

 
    
Four Months Ended September 28,
2002

    
Five Months Ended
June 1,
2002

    
Nine Months Ended September 29,
2001

 
Net sales
  
$
313,819
 
  
380,050
 
  
772,541
 
Cost of goods sold
  
 
289,141
 
  
371,941
 
  
769,033
 
    


  

  

Gross profit
  
 
24,678
 
  
8,109
 
  
3,508